BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28347324)

  • 1. PMS2 gene mutation results in DNA mismatch repair system failure in a case of adult granulosa cell tumor.
    Wang WC; Lee YT; Lai YC
    J Ovarian Res; 2017 Mar; 10(1):22. PubMed ID: 28347324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathogenesis in granulosa cell tumor is not only due to somatic FOXL2 mutation.
    Wang WC; Lai YC
    J Ovarian Res; 2014 Sep; 7():88. PubMed ID: 25297715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
    Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
    Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors.
    Hes O; Vaněček T; Petersson F; Grossmann P; Hora M; Perez Montiel DM; Steiner P; Dvořák M; Michal M
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):347-51. PubMed ID: 21293260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
    Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
    N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitfalls in molecular analysis for mismatch repair deficiency in a family with biallelic pms2 germline mutations.
    Leenen CH; Geurts-Giele WR; Dubbink HJ; Reddingius R; van den Ouweland AM; Tops CM; van de Klift HM; Kuipers EJ; van Leerdam ME; Dinjens WN; Wagner A
    Clin Genet; 2011 Dec; 80(6):558-65. PubMed ID: 21204794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor.
    McCluggage WG; Singh N; Kommoss S; Huntsman DG; Gilks CB
    Am J Surg Pathol; 2013 Sep; 37(9):1450-5. PubMed ID: 23774170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency.
    Clay MR; Allison KH; Folkins AK; Longacre TA
    Am J Surg Pathol; 2014 Nov; 38(11):1494-500. PubMed ID: 24921635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.
    Yanagida S; Anglesio MS; Nazeran TM; Lum A; Inoue M; Iida Y; Takano H; Nikaido T; Okamoto A; Huntsman DG
    PLoS One; 2017; 12(6):e0178989. PubMed ID: 28594898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation.
    Lee S; Kim TH; Won M; Ko JJ; Rho J; Lee K; Bae J
    Int J Gynecol Cancer; 2010 Nov; 20(8):1341-3. PubMed ID: 21051974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXL2 mutations in granulosa cell tumors occurring in males.
    Lima JF; Jin L; de Araujo AR; Erikson-Johnson MR; Oliveira AM; Sebo TJ; Keeney GL; Medeiros F
    Arch Pathol Lab Med; 2012 Jul; 136(7):825-8. PubMed ID: 22742556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome.
    Carneiro da Silva F; Ferreira JR; Torrezan GT; Figueiredo MC; Santos ÉM; Nakagawa WT; Brianese RC; Petrolini de Oliveira L; Begnani MD; Aguiar-Junior S; Rossi BM; Ferreira Fde O; Carraro DM
    PLoS One; 2015; 10(10):e0139753. PubMed ID: 26437257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.
    Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG
    Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary.
    Färkkilä A; Haltia UM; Tapper J; McConechy MK; Huntsman DG; Heikinheimo M
    Ann Med; 2017 Aug; 49(5):435-447. PubMed ID: 28276867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
    Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F
    Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.
    Kommoss S; Anglesio MS; Mackenzie R; Yang W; Senz J; Ho J; Bell L; Lee S; Lorette J; Huntsman DG; Blake Gilks C
    Mod Pathol; 2013 Jun; 26(6):860-7. PubMed ID: 23348906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
    Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
    Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
    Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
    Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.